Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

NCT07457775 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma (Excluding GIST)

Interventions

DRUG: Irinotecan Hydrochloride Liposome Injection(II) combined with temozolomide and bevacizuma

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University